Trial intelligence / Profile preview

Terbinafine shampoo for severe dandruff conditions

2011-000852-40Phase 2Completed

Sponsor
Dermal Laboratories
Start
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, double-blind trial of Terbicol in dandruff and seborrheic dermatitis (SD) (2 arms), sponsored by Dermal Laboratories. Primary endpoint: Improvement in overall dandruff severity score. Started Jun 2012; status: completed.

02

Drugs

Terbicol
03

Conditions

dandruffseborrheic dermatitis (SD)

Beyond the preview

Go deeper on 2011-000852-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000852-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call